JULIAN MOLINA, M.D.

Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l

Administration of chemotherapy into vein, 1 hour or less

New patient office or other outpatient visit, 60-74 minutes

Established patient office or other outpatient visit, 40-54 minutes

Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes

Leuprolide acetate (for depot suspension), 7.5 mg

Administration of additional new drug or substance into vein, 1 hour or less

Administration of additional new drug or substance into vein using push technique

Established patient office or other outpatient visit, 30-39 minutes

Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle

Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes

Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less

Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle

Administration of chemotherapy into vein, each additional hour

Injection, daratumumab, 10 mg and hyaluronidase-fihj

Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg

Injection of additional new drug or substance into vein

Injection, pembrolizumab, 1 mg

Collection of blood sample from implanted device

Infusion into a vein for hydration, each additional hour

Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion

Injection, nivolumab, 1 mg

Infusion, normal saline solution , 1000 cc

Infusion, normal saline solution, sterile (500 ml = 1 unit)

Injection of drug or substance under skin or into muscle

Injection, diphenhydramine hcl, up to 50 mg

Unclassified drugs

Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

Injection, carboplatin, 50 mg

Injection, fluorouracil, 500 mg

Injection, irinotecan, 20 mg

Injection, leucovorin calcium, per 50 mg

Injection, palonosetron hcl, 25 mcg

Injection, bortezomib, 0.1 mg

Injection, ondansetron hydrochloride, per 1 mg

Injection, dexamethasone sodium phosphate, 1 mg

Injection, paclitaxel, 1 mg

Injection, atropine sulfate, 0.01 mg

Injection, fosaprepitant, 1 mg

Injection, oxaliplatin, 0.5 mg